William Laughlin

PhD, Senior Business Analyst, Value & Development Consulting

William supports project leadership on all tasks and deliverables across the project lifecycle. He has experience across a range of project types in multiple therapy areas. This includes scientific advice, encompassing multiple joint HTA-regulatory and HTA-only engagements across a broad range of therapy areas that include oncology, cardiovascular, and rare diseases. He is responsible for background research and targeted literature searches to develop briefing book questions and write company positions and product value propositions. Additionally, William has experience conducting a number of payer research projects including value message, price and TPP testing in multiple therapy areas including oncology, immunology and transplant, and infectious disease. He is responsible for the development of background materials and discussion guides, identifying and engaging with key stakeholders, and organizing and conducting interview programs, including analysis, interpretation, and presentation of results.

William has a PhD in cell biology research from University College London and an MSc and BSc from Imperial College London. Prior to joining Evidera, he worked for several years in biomedical research as a doctoral and post-doctoral researcher, where he contributed to publications in peer-reviewed journals and international conferences and developed novel cell biology techniques.